BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu L, Dai Y, Chen J, Zeng T, Li Y, Chen L, Zhu YH, Li J, Li Y, Ma S. Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling. Hepatology. 2014;59:531-543. [PMID: 23929794 DOI: 10.1002/hep.26677] [Cited by in Crossref: 81] [Cited by in F6Publishing: 80] [Article Influence: 10.1] [Reference Citation Analysis]
Number Citing Articles
1 Lee TK, Guan XY, Ma S. Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34504325 DOI: 10.1038/s41575-021-00508-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xiao KH, Teng K, Ye YL, Tan L, Chen MK, Liang HT, Feng ZH, Duan JL, Deng MH, Wei WS, Luo JH, Qin ZK, Xie D. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling. Cancer Sci 2019;110:2822-33. [PMID: 31278883 DOI: 10.1111/cas.14126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Fang F, Chang RM, Yu L, Lei X, Xiao S, Yang H, Yang LY. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. J Hepatol. 2015;63:874-885. [PMID: 25998163 DOI: 10.1016/j.jhep.2015.05.008] [Cited by in Crossref: 103] [Cited by in F6Publishing: 114] [Article Influence: 17.2] [Reference Citation Analysis]
4 Jayachandran A, Dhungel B, Steel JC. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma. J Hematol Oncol. 2016;9:74. [PMID: 27578206 DOI: 10.1186/s13045-016-0307-9] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 17.6] [Reference Citation Analysis]
5 Abbaszadegan MR, Taghehchian N, Aarabi A, Moghbeli M. MAEL Cancer-Testis Antigen as a Diagnostic Marker in Primary Stages of Gastric Cancer with Helicobacter pylori Infection. J Gastrointest Cancer 2020;51:17-22. [PMID: 30488287 DOI: 10.1007/s12029-018-0183-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lee E, Lokman NA, Oehler MK, Ricciardelli C, Grutzner F. A Comprehensive Molecular and Clinical Analysis of the piRNA Pathway Genes in Ovarian Cancer. Cancers (Basel) 2020;13:E4. [PMID: 33374923 DOI: 10.3390/cancers13010004] [Reference Citation Analysis]
7 Wu Y, Zhang J, Zhang X, Zhou H, Liu G, Li Q. Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy. Front Pharmacol 2020;11:198. [PMID: 32210805 DOI: 10.3389/fphar.2020.00198] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
8 Huang LL, Zhang Y, Zhang JX, He LJ, Lai YR, Liao YJ, Tian XP, Deng HX, Liang YJ, Kung HF, Xie D, Zhu SL. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma. Tumour Biol 2015;36:4405-15. [PMID: 25596704 DOI: 10.1007/s13277-015-3080-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
9 Tang X, Cao T, Zhu Y, Zhang L, Chen J, Liu T, Ming X, Fang S, Yuan YF, Jiang L, Huang JD, Guan XY. PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway. Cell Death Dis 2020;11:510. [PMID: 32641749 DOI: 10.1038/s41419-020-2700-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
10 Zahan T, Das PK, Akter SF, Habib R, Rahman MH, Karim MR, Islam F. Therapy Resistance in Cancers: Phenotypic, Metabolic, Epigenetic and Tumour Microenvironmental Perspectives. Anticancer Agents Med Chem 2020;20:2190-206. [PMID: 32748758 DOI: 10.2174/1871520620999200730161829] [Reference Citation Analysis]
11 Liu T, Yu J, Ge C, Zhao F, Miao C, Jin W, Su Y, Geng Q, Chen T, Xie H, Cui Y, Yao M, Li J, Hou H, Li H. B-Cell Receptor-Associated Protein 31 Promotes Metastasis via AKT/β-Catenin/Snail Pathway in Hepatocellular Carcinoma. Front Mol Biosci 2021;8:656151. [PMID: 34179078 DOI: 10.3389/fmolb.2021.656151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang N, Chen S, Zhang B, Li S, Jin F, Gao D, Liu H, Jiang Y. 8u, a pro-apoptosis/cell cycle arrest compound, suppresses invasion and metastasis through HSP90α downregulating and PI3K/Akt inactivation in hepatocellular carcinoma cells. Sci Rep 2018;8:309. [PMID: 29321577 DOI: 10.1038/s41598-017-18701-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
13 Tian QX, Zhang ZH, Ye QL, Xu S, Hong Q, Xing WY, Chen L, Yu DX, Xu DX, Xie DD. Melatonin Inhibits Migration and Invasion in LPS-Stimulated and -Unstimulated Prostate Cancer Cells Through Blocking Multiple EMT-Relative Pathways. J Inflamm Res 2021;14:2253-65. [PMID: 34079331 DOI: 10.2147/JIR.S305450] [Reference Citation Analysis]
14 Liu M, Jiang L, Guan XY. The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update. Protein Cell 2014;5:673-91. [PMID: 24916440 DOI: 10.1007/s13238-014-0065-9] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 11.4] [Reference Citation Analysis]
15 Yang H, Li XD, Zhou Y, Ban X, Zeng TT, Li L, Zhang BZ, Yun J, Xie D, Guan XY, Li Y. Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma. Oncotarget. 2015;6:26079-26089. [PMID: 26317793 DOI: 10.18632/oncotarget.4581] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
16 Dong S, Kong J, Kong F, Kong J, Gao J, Ji L, Pan B, Chen L, Zheng L, Sun W. Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation. BMC Cancer 2015;15:939. [PMID: 26620566 DOI: 10.1186/s12885-015-1949-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
17 Zhao Y, Wang J, Xu C, Li Y, Sun B, Yang L. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling. Clinical Science 2019;133:1645-62. [DOI: 10.1042/cs20190225] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
18 Li X, Zhang J, Jiang L, Wang F, Liu L, Liao Y, Jin X, Chen W, Chen X, Guo S, Zhou F, Zeng Y, Guan X, Liu Z, Xie D. Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B. Oncogene 2016;35:6281-92. [DOI: 10.1038/onc.2016.165] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
19 Tan L, Tang Y, Li H, Li P, Ye Y, Cen J, Gui C, Luo J, Cao J, Wei J. N6-Methyladenosine Modification of LncRNA DUXAP9 Promotes Renal Cancer Cells Proliferation and Motility by Activating the PI3K/AKT Signaling Pathway. Front Oncol 2021;11:641833. [PMID: 34168980 DOI: 10.3389/fonc.2021.641833] [Reference Citation Analysis]
20 Zhang X, Ning Y, Xiao Y, Duan H, Qu G, Liu X, Du Y, Jiang D, Zhou J. MAEL contributes to gastric cancer progression by promoting ILKAP degradation. Oncotarget 2017;8:113331-44. [PMID: 29371914 DOI: 10.18632/oncotarget.22970] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
21 Rizzo F, Rinaldi A, Marchese G, Coviello E, Sellitto A, Cordella A, Giurato G, Nassa G, Ravo M, Tarallo R, Milanesi L, Destro A, Torzilli G, Roncalli M, Di Tommaso L, Weisz A. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma. Oncotarget 2016;7:54650-61. [PMID: 27429044 DOI: 10.18632/oncotarget.10567] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 13.7] [Reference Citation Analysis]
22 Lan Y, Han J, Wang Y, Wang J, Yang G, Li K, Song R, Zheng T, Liang Y, Pan S, Liu X, Zhu M, Liu Y, Meng F, Mohsin M, Cui Y, Zhang B, Subash S, Liu L. STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma. Cell Death Dis 2018;9:236. [PMID: 29445189 DOI: 10.1038/s41419-018-0262-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
23 Sun WY, Hu SS, Wu JJ, Huang Q, Ma Y, Wang QT, Chen JY, Wei W. Down-regulation of β-arrestin2 promotes tumour invasion and indicates poor prognosis of hepatocellular carcinoma. Sci Rep 2016;6:35609. [PMID: 27759077 DOI: 10.1038/srep35609] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
24 Hou KZ, Fu ZQ, Gong H. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition. World J Gastroenterol 2015; 21(2): 475-483 [PMID: 25593462 DOI: 10.3748/wjg.v21.i2.475] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
25 Fang C, Zhang Z, Liu C, Wang G, Wang F, Zhao Z, Li W, Hua J, Shuang J, Du J. Gastrointestinal Factor GDDR Attenuates Epithelial-Mesenchymal Transition in Gastric Cancer via Inhibiting AKT Signal. Dig Dis Sci 2016;61:1941-9. [PMID: 27017226 DOI: 10.1007/s10620-016-4115-4] [Reference Citation Analysis]
26 Zhang C, Wei S, Sun WP, Teng K, Dai MM, Wang FW, Chen JW, Ling H, Ma XD, Feng ZH, Duan JL, Cai MY, Xie D. Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of Hepatocellular Carcinoma. Theranostics 2020;10:9066-82. [PMID: 32802179 DOI: 10.7150/thno.45349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
27 McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Sokolosky M, Abrams SL, Montalto G, D'Assoro AB, Libra M, Nicoletti F, Maestro R, Basecke J, Rakus D, Gizak A, Demidenko ZN, Cocco L, Martelli AM, Cervello M. GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget 2014;5:2881-911. [PMID: 24931005 DOI: 10.18632/oncotarget.2037] [Cited by in Crossref: 280] [Cited by in F6Publishing: 278] [Article Influence: 46.7] [Reference Citation Analysis]
28 Xie X, Wang X, Liao W, Fei R, Wu N, Cong X, Chen Q, Wei L, Wang Y, Chen H. PPPDE1 promotes hepatocellular carcinoma development by negatively regulate p53 and apoptosis. Apoptosis 2019;24:135-44. [DOI: 10.1007/s10495-018-1491-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
29 Yin JH, Elumalai P, Kim SY, Zhang SZ, Shin S, Lee M, Chung YJ. TNNC1 knockout reverses metastatic potential of ovarian cancer cells by inactivating epithelial-mesenchymal transition and suppressing F-actin polymerization. Biochem Biophys Res Commun 2021;547:44-51. [PMID: 33592378 DOI: 10.1016/j.bbrc.2021.02.021] [Reference Citation Analysis]
30 Peng B, Ortega J, Gu L, Chang Z, Li GM. Phosphorylation of proliferating cell nuclear antigen promotes cancer progression by activating the ATM/Akt/GSK3β/Snail signaling pathway. J Biol Chem 2019;294:7037-45. [PMID: 30858175 DOI: 10.1074/jbc.RA119.007897] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 4.5] [Reference Citation Analysis]
31 Dong Q, Cai N, Tao T, Zhang R, Yan W, Li R, Zhang J, Luo H, Shi Y, Luan W, Zhang Y, You Y, Wang Y, Liu N. An axis involving SNAI1, microRNA-128 and SP1 modulates glioma progression. PLoS One 2014;9:e98651. [PMID: 24959930 DOI: 10.1371/journal.pone.0098651] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
32 Cervello M, Augello G, Cusimano A, Emma MR, Balasus D, Azzolina A, Mccubrey JA, Montalto G. Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma. Advances in Biological Regulation 2017;65:59-76. [DOI: 10.1016/j.jbior.2017.06.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
33 Zhang Y, Tao X, Jin G, Jin H, Wang N, Hu F, Luo Q, Shu H, Zhao F, Yao M, Fang J, Cong W, Qin W, Wang C. A Targetable Molecular Chaperone Hsp27 Confers Aggressiveness in Hepatocellular Carcinoma. Theranostics 2016;6:558-70. [PMID: 26941848 DOI: 10.7150/thno.14693] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
34 Liu M, Jiang L, Guan XY. The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update. Protein Cell. 2014;5:673-691. [PMID: 24916440 DOI: 10.1007/s13238- 014-0065-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Zhou JJ, Meng Z, He XY, Cheng D, Ye HL, Deng XG, Chen RF. Hepatitis C virus core protein increases Snail expression and induces epithelial-mesenchymal transition through the signal transducer and activator of transcription 3 pathway in hepatoma cells. Hepatol Res 2017;47:574-83. [PMID: 27381678 DOI: 10.1111/hepr.12771] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
36 Tao F, Ruan S, Liu W, Wang L, Xiong Y, Shen M. Fuling Granule, a Traditional Chinese Medicine Compound, Suppresses Cell Proliferation and TGFβ-Induced EMT in Ovarian Cancer. PLoS One 2016;11:e0168892. [PMID: 28036353 DOI: 10.1371/journal.pone.0168892] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
37 Liu JJ, Li LZ, Xu P. Upregulation of TRPM8 can promote the colon cancer liver metastasis through mediating Akt/GSK-3 signal pathway. Biotechnol Appl Biochem 2021. [PMID: 33432591 DOI: 10.1002/bab.2102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Pan J, Fan Z, Wang Z, Dai Q, Xiang Z, Yuan F, Yan M, Zhu Z, Liu B, Li C. CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway. J Exp Clin Cancer Res 2019;38:52. [PMID: 30717785 DOI: 10.1186/s13046-019-1049-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 20.5] [Reference Citation Analysis]
39 Wen-Jian Y, Song T, Jun T, Kai-Ying X, Jian-Jun W, Si-Hua W. NF45 promotes esophageal squamous carcinoma cell invasion by increasing Rac1 activity through 14-3-3ε protein. Arch Biochem Biophys 2019;663:101-8. [PMID: 30550728 DOI: 10.1016/j.abb.2018.12.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
40 Cong WM, Wu MC. New insights into molecular diagnostic pathology of primary liver cancer: Advances and challenges. Cancer Lett 2015;368:14-9. [PMID: 26276723 DOI: 10.1016/j.canlet.2015.07.043] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
41 Zhang L, Chen J, Ning D, Liu Q, Wang C, Zhang Z, Chu L, Yu C, Liang HF, Zhang B, Chen X. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21. J Exp Clin Cancer Res 2019;38:101. [PMID: 30808376 DOI: 10.1186/s13046-019-1058-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
42 Liang X, Zeng J, Wang L, Shen L, Ma X, Li S, Wu Y, Ma L, Ci X, Guo Q, Jia M, Shen H, Sun Y, Liu Z, Liu S, Li W, Yu H, Chen C, Jia J. Histone demethylase RBP2 promotes malignant progression of gastric cancer through TGF-β1-(p-Smad3)-RBP2-E-cadherin-Smad3 feedback circuit. Oncotarget 2015;6:17661-74. [PMID: 25974964 DOI: 10.18632/oncotarget.3756] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
43 Guo W, Yu Q, Zhang M, Li F, Liu Y, Jiang W, Jiang H, Li H. Long intergenic non-protein coding RNA 511 promotes the progression of osteosarcoma cells through sponging microRNA 618 to upregulate the expression of maelstrom. Aging (Albany NY) 2019;11:5351-67. [PMID: 31386627 DOI: 10.18632/aging.102109] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
44 Wang Z, Qu L, Deng B, Sun X, Wu S, Liao J, Fan J, Peng Z. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling. Sci Rep 2016;6:33205. [PMID: 27628214 DOI: 10.1038/srep33205] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
45 Dai Y, Liu L, Zeng T, Liang J, Song Y, Chen K, Li Y, Chen L, Zhu Y, Li J, Li Y, Xie D, Yuan Y, Guan X. Overexpression of MUC13, a Poor Prognostic Predictor, Promotes Cell Growth by Activating Wnt Signaling in Hepatocellular Carcinoma. The American Journal of Pathology 2018;188:378-91. [DOI: 10.1016/j.ajpath.2017.10.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
46 Xue TC, Ge NL, Xu X, Le F, Zhang BH, Wang YH. High platelet counts increase metastatic risk in huge hepatocellular carcinoma undergoing transarterial chemoembolization. Hepatol Res 2016;46:1028-36. [PMID: 26776560 DOI: 10.1111/hepr.12651] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
47 Jia X, Li Z, Dong L, Sun G, Wang X, Gao J, Li Y, Wu Y, An W. Lack of hepatic stimulator substance expression promotes hepatocellular carcinoma metastasis partly through ERK-activated epithelial–mesenchymal transition. Lab Invest 2018;98:871-82. [DOI: 10.1038/s41374-018-0039-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 He L, Deng H, Liu S, Chen J, Li B, Wang C, Wang X, Jiang Y, Ma N, Liu M, Xie D. Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4. Cancer Commun (Lond) 2018;38:53. [PMID: 30103827 DOI: 10.1186/s40880-018-0320-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
49 Huang S, Huang C, Chen W, Liu Y, Yin X, Lai J, Liang L, Wang Q, Wang A, Zheng C. WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer. Int J Oncol 2018;53:672-84. [PMID: 29845225 DOI: 10.3892/ijo.2018.4421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
50 Liu X, Li T, Huang X, Wu W, Li J, Wei L, Qian Y, Xu H, Wang Q, Wang L. DEPDC1B promotes migration and invasion in pancreatic ductal adenocarcinoma by activating the Akt/GSK3β/Snail pathway. Oncol Lett 2020;20:146. [PMID: 32934714 DOI: 10.3892/ol.2020.12009] [Reference Citation Analysis]
51 Zhang Y, Wu X, Li Y, Zhang H, Li Z, Zhang Y, Zhang L, Ju J, Liu X, Chen X, Glybochko PV, Nikolenko V, Kopylov P, Xu C, Yang B. Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis. Sci Rep 2016;6:33787. [PMID: 27671604 DOI: 10.1038/srep33787] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
52 Chang RM, Yang H, Fang F, Xu JF, Yang LY. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase. Hepatology. 2014;60:1251-1263. [PMID: 24825302 DOI: 10.1002/hep.27221] [Cited by in Crossref: 107] [Cited by in F6Publishing: 104] [Article Influence: 15.3] [Reference Citation Analysis]
53 McCubrey JA, Fitzgerald TL, Yang LV, Lertpiriyapong K, Steelman LS, Abrams SL, Montalto G, Cervello M, Neri LM, Cocco L, Martelli AM, Laidler P, Dulińska-Litewka J, Rakus D, Gizak A, Nicoletti F, Falzone L, Candido S, Libra M. Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells. Oncotarget 2017;8:14221-50. [PMID: 27999207 DOI: 10.18632/oncotarget.13991] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 14.3] [Reference Citation Analysis]
54 Li Q, Wei P, Huang B, Xu Y, Li X, Li Y, Cai S, Li D. MAEL expression links epithelial-mesenchymal transition and stem cell properties in colorectal cancer. Int J Cancer 2016;139:2502-11. [PMID: 27537253 DOI: 10.1002/ijc.30388] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
55 Tsui YM, Chan LK, Ng IO. Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential. Br J Cancer 2020;122:1428-40. [PMID: 32231294 DOI: 10.1038/s41416-020-0823-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
56 Li T, Li S, Chen D, Chen B, Yu T, Zhao F, Wang Q, Yao M, Huang S, Chen Z, He X. Transcriptomic analyses of RNA-binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma. Cancer Sci 2017;108:877-85. [PMID: 28231410 DOI: 10.1111/cas.13209] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
57 Wang JL, Yang MY, Xiao S, Sun B, Li YM, Yang LY. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling. J Exp Clin Cancer Res 2018;37:45. [PMID: 29506567 DOI: 10.1186/s13046-018-0720-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
58 Hu Y, Yu K, Wang G, Zhang D, Shi C, Ding Y, Hong D, Zhang D, He H, Sun L, Zheng J, Sun S, Qian F. Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell. Biochemical Pharmacology 2018;150:280-92. [DOI: 10.1016/j.bcp.2018.02.023] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
59 He Z, Dong W, Li Q, Qin C, Li Y. Sauchinone prevents TGF-β-induced EMT and metastasis in gastric cancer cells. Biomedicine & Pharmacotherapy 2018;101:355-61. [DOI: 10.1016/j.biopha.2018.02.121] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
60 Li YL, Rao MJ, Zhang NY, Wu LW, Lin NM, Zhang C. BAY 87-2243 sensitizes hepatocellular carcinoma Hep3B cells to histone deacetylase inhibitors treatment via GSK-3β activation. Exp Ther Med 2019;17:4547-53. [PMID: 31186678 DOI: 10.3892/etm.2019.7500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
61 Chen L, Fu H, Luo Y, Chen L, Cheng R, Zhang N, Guo H. cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling. Cell Death Dis 2017;8:e2728. [PMID: 28383549 DOI: 10.1038/cddis.2017.152] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
62 Chen C, Tsukamoto H, Machida K. Oncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity. Hepatol Int 2014;8:330-8. [DOI: 10.1007/s12072-014-9545-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
63 Tong S, Xia T, Fan K, Jiang K, Zhai W, Li JS, Wang SH, Wang JJ. 14-3-3ζ promotes lung cancer cell invasion by increasing the Snail protein expression through atypical protein kinase C (aPKC)/NF-κB signaling. Exp Cell Res 2016;348:1-9. [PMID: 27554601 DOI: 10.1016/j.yexcr.2016.08.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
64 Pfeifer GP. Defining Driver DNA Methylation Changes in Human Cancer. Int J Mol Sci 2018;19:E1166. [PMID: 29649096 DOI: 10.3390/ijms19041166] [Cited by in Crossref: 117] [Cited by in F6Publishing: 102] [Article Influence: 39.0] [Reference Citation Analysis]
65 Kim SH, Park ER, Cho E, Jung WH, Jeon JY, Joo HY, Lee KH, Shin HJ. Mael is essential for cancer cell survival and tumorigenesis through protection of genetic integrity. Oncotarget 2017;8:5026-37. [PMID: 27926513 DOI: 10.18632/oncotarget.13756] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
66 郭艳, 王茜, 杨志杰. 原发性肝细胞癌CDC25A的表达与多普勒超声影像特征的关联性分析. 世界华人消化杂志 2013; 21(26): 2649-2654 [DOI: 10.11569/wcjd.v21.i26.2649] [Reference Citation Analysis]
67 Yang J, Hou Y, Zhou M, Wen S, Zhou J, Xu L, Tang X, Du YE, Hu P, Liu M. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network. Int J Biochem Cell Biol 2016;71:62-71. [PMID: 26693891 DOI: 10.1016/j.biocel.2015.12.004] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
68 Barrette K, Van Kelst S, Wouters J, Marasigan V, Fieuws S, Agostinis P, Oord J, Garmyn M. Epithelial‐mesenchymal transition during invasion of cutaneous squamous cell carcinoma is paralleled by AKT activation. Br J Dermatol 2014;171:1014-21. [DOI: 10.1111/bjd.12967] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
69 Qian Y, Yao W, Yang T, Yang Y, Liu Y, Shen Q, Zhang J, Qi W, Wang J. aPKC-ι/P-Sp1/Snail signaling induces epithelial-mesenchymal transition and immunosuppression in cholangiocarcinoma. Hepatology 2017;66:1165-82. [DOI: 10.1002/hep.29296] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 10.5] [Reference Citation Analysis]
70 Chen WH, Cai MY, Zhang JX, Wang FW, Tang LQ, Liao YJ, Jin XH, Wang CY, Guo L, Jiang YG, Ren CP, Mai HQ, Zeng MS, Kung HF, Qian CN, Xie D. FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1. Oncogene 2018;37:6243-58. [PMID: 30013189 DOI: 10.1038/s41388-018-0351-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
71 Abbaszadegan MR, Taghehchian N, Aarabi A, Akbari F, Saburi E, Moghbeli M. MAEL as a diagnostic marker for the early detection of esophageal squamous cell carcinoma. Diagn Pathol 2021;16:36. [PMID: 33902648 DOI: 10.1186/s13000-021-01098-z] [Reference Citation Analysis]
72 Van Tongelen A, Loriot A, De Smet C. Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes. Cancer Letters 2017;396:130-7. [DOI: 10.1016/j.canlet.2017.03.029] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 19.3] [Reference Citation Analysis]
73 Zhang M, Zhang H, Cheng S, Zhang D, Xu Y, Bai X, Xia S, Zhang L, Ma J, Du M, Wang Y, Wang J, Chen M, Leng J. Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells. Tumour Biol 2014;35:7135-45. [PMID: 24760275 DOI: 10.1007/s13277-014-1963-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
74 Zheng X, Chen S, Yang Q, Cai J, Zhang W, You H, Xing J, Dong Y. Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2. Cancer Biol Ther 2015;16:1407-14. [PMID: 26176734 DOI: 10.1080/15384047.2015.1070990] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
75 Lai KP, Cheung A, Ho CH, Tam NY, Li JW, Lin X, Chan TF, Lee NP, Li R. Transcriptomic analysis reveals the oncogenic role of S6K1 in hepatocellular carcinoma. J Cancer 2020;11:2645-55. [PMID: 32201535 DOI: 10.7150/jca.40726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
76 Lim SL, Ricciardelli C, Oehler MK, Tan IM, Russell D, Grützner F. Overexpression of piRNA pathway genes in epithelial ovarian cancer. PLoS One 2014;9:e99687. [PMID: 24932571 DOI: 10.1371/journal.pone.0099687] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
77 Zhang Y, Zhang JX, Huang LL, He LJ, Liao YJ, Lai YR, Deng HX, Tian XP, Kung HF, Xie D, Zhu SL. Low expression of BARX2 in human primary hepatocellular carcinoma correlates with metastasis and predicts poor prognosis. Hepatol Res 2015;45:228-37. [PMID: 24716715 DOI: 10.1111/hepr.12340] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
78 Jiang H, Zhou Z, Jin S, Xu K, Zhang H, Xu J, Sun Q, Wang J, Xu J. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Sci 2018;109:1414-27. [PMID: 29603830 DOI: 10.1111/cas.13598] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
79 Fei Y, Xiong Y, Shen X, Zhao Y, Zhu Y, Wang L, Liang Z. Cathepsin L promotes ionizing radiation-induced U251 glioma cell migration and invasion through regulating the GSK-3β/CUX1 pathway. Cellular Signalling 2018;44:62-71. [DOI: 10.1016/j.cellsig.2018.01.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
80 Xu Z, Zhou Z, Zhang J, Xuan F, Fan M, Zhou D, Liuyang Z, Ma X, Hong Y, Wang Y, Sharma S, Dong Q, Wang G. Targeting BMI-1-mediated epithelial-mesenchymal transition to inhibit colorectal cancer liver metastasis. Acta Pharm Sin B 2021;11:1274-85. [PMID: 34094833 DOI: 10.1016/j.apsb.2020.11.018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]